What are baseline criteria for extracorporeal membrane oxygenation (ECMO) in the treatment of persistent pulmonary hypertension of the newborn (PPHN)?

Updated: Sep 03, 2019
  • Author: Kate A Tauber, MD; Chief Editor: Howard S Weber, MD, FSCAI  more...
  • Print


Baseline criteria for consideration for ECMO include an evaluation of risk factors, because of the invasive nature of the therapy and a need for heparinization.

Baseline criteria for newborns considered for ECMO are generally as follows:

  • Gestation of more than 34 weeks

  • Weight more than 2000 g

  • No major intracranial hemorrhage on cranial sonograms (ie, larger than a grade II hemorrhage)

  • Reversible lung disease

  • No evidence of lethal congenital anomalies or congenital heart disease resulting in hypoxemia that is clinically presenting similar to PPHN

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!